FDA Inspection 1306578 — John D. Gabriel, MD

John D. Gabriel, MD — FEI 3003947557

The FDA completed an inspection of John D. Gabriel, MD on March 9, 2026 in North Richland Hills, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Richland Hills, TX (United States)

Additional Details

Clinical Investigator (CI)